This is a preview of subscription content, log in via an institution to check access.
References
Molimard M, Girodet PO, Pollet C, Fourrier-Réglat A, Daveluy A, Haramburu F, Fayon M, Tabarin A (2008) Adrenal insufficiency with inhaled corticosteroids: prevalence and clinical presentation. Drug Saf 31:769–774
Varis T, Kivisto KT, Neuvonen PJ (2000) The effects of itraconazole on the pharmacokinetics and pharmacodynamics of oral prednisolone. Eur J Clin Pharmacol 56:57–60
Varis T, Kivisto KT, Neuvonen PJ (2000) The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect. Clin Pharmacol Ther 68:487–494
Fost DA, Leung DY, Martin RJ, Brown EE, Szefler SJ, Spahn JD (1999) Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy. J Allergy Clin Immunol 103:1031–1035
Varis T, Kivisto KT, Neuvonen PJ (2000) Grapefruit juice can increase the plasma concentrations of oral methylprednisolone. Eur J Clin Pharmacol 56:489–493
Varis T, Backman JT, Kivistö KT, Neuvonen PJ (2000) Diltiazem and mibefradil increase the plasma concentrations and greatly enhance the adrenal-suppressant effect of oral methylprednisolone. Clin Pharmacol Ther 67:215–221
Jönsson G, Aström A, Andersson P (1995) Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver. Drug Metab Dispos 23:137–42
Pearce RE, Leeder JS, Kearns GL (2006) Biotransformation of fluticasone: in vitro characterization. Drug Metab Dispos 34:1035–40
Woods DR, Arun CS, Corris PA, Perros P (2006) Cushing’s syndrome without excess cortisol. BMJ 332:469–470
Parmar JS, Howell T, Kelly J, Bilton D (2002) Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis. Thorax 57:749–750
Schmid C, Naef R, Speich R, Boehler A (2003) Addition of inhaled fluticasone propionate to systemic immunosuppression after lung transplantation: Cushing’s syndrome in patients on itraconazole comedication. Transplantation 76:263–264
Bolland MJ, Bagg W, Thomas MG, Lucas JA, Ticehurst R, Black PN (2004) Cushing’s syndrome due to interaction between inhaled corticosteroids and itraconazole. Ann Pharmacother 38:46–49
De Wachter E, Malfroot A, De Schutter I, Vanbesien J, De Schepper J (2003) Inhaled budesonide induced Cushing’s syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450. J Cyst Fibros 2:72–75
Skov M, Main KM, Sillesen IB, Müller J, Koch C, Lanng S (2002) Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide. Eur Respir J 20:127–133
Raaska K, Niemi M, Neuvonen M, Neuvonen PJ, Kivistö KT (2002) Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole. Clin Pharmacol Ther 72:362–369
Foisy MM, Yakiwchuk EM, Chiu I, Singh AE (2008) Adrenal suppression and Cushing’s syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature. HIV Med 9:389–396
Ahle GB, Blum AL, Martinek J, Oneta CM, Dorta G (2000) Cushing’s syndrome in an 81-year-old patient treated with budesonide and amiodarone. Eur J Gastroenterol Hepatol 12:1041–1042
Boobis AR (1998) Comparative physicochemical and pharmacokinetic profiles of inhaled beclomethasone dipropionate and budesonide. Respir Med 92:2–6
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Daveluy, A., Raignoux, C., Miremont-Salamé, G. et al. Drug interactions between inhaled corticosteroids and enzymatic inhibitors. Eur J Clin Pharmacol 65, 743–745 (2009). https://doi.org/10.1007/s00228-009-0653-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-009-0653-4